NCT04261049View on ClinicalTrials.gov

Effect of Zilretta Injection

PHASE1CompletedINTERVENTIONAL
Enrollment

35

Participants

Timeline

Start Date

August 1, 2020

Primary Completion Date

January 10, 2022

Study Completion Date

January 10, 2022

Conditions
Osteoarthritis, Knee
Interventions
DRUG

Triamcinolone Acetonide Extended-Release Injectable Suspension

A single ZILRETTA® (triamcinolone acetonide extended-release injectable suspension) intra-articular knee injection.

Trial Locations (1)

27516

MOTION Science Institute, Chapel Hill

Sponsors
All Listed Sponsors
collaborator

Pacira Pharmaceuticals, Inc

INDUSTRY

lead

University of North Carolina, Chapel Hill

OTHER

NCT04261049 - Effect of Zilretta Injection | Biotech Hunter | Biotech Hunter